兰卫医学
(301060)
| 流通市值：34.18亿 | | | 总市值：38.01亿 |
| 流通股本：3.60亿 | | | 总股本：4.01亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 846,051,059.17 | 759,495,486.65 | 744,954,061.17 | 707,630,098.06 |
| 应收票据及应收账款 | 659,100,198.83 | 684,763,582.74 | 728,645,093.59 | 818,044,061.68 |
| 其中：应收票据 | 1,363,075.16 | 1,852,214.03 | 1,674,235.99 | 1,231,179.14 |
| 应收账款 | 657,737,123.67 | 682,911,368.71 | 726,970,857.6 | 816,812,882.54 |
| 应收款项融资 | 8,143,204.91 | 307,491.89 | 1,055,639.65 | 4,441,890.82 |
| 预付款项 | 2,365,547.85 | 2,535,889.79 | 4,870,297.73 | 3,883,493.2 |
| 其他应收款合计 | 4,963,445.81 | 4,915,470.74 | 8,039,292.1 | 7,810,547.36 |
| 存货 | 280,918,068.78 | 269,812,838.16 | 319,963,258.21 | 328,539,465.38 |
| 合同资产 | 905,850 | 1,063,290 | 461,440 | 496,850 |
| 其他流动资产 | 29,536,056.94 | 28,917,555.68 | 35,710,007.91 | 36,755,439.13 |
| 流动资产合计 | 1,831,983,432.29 | 1,751,811,605.65 | 1,843,699,090.36 | 1,907,601,845.63 |
| 非流动资产: | | | | |
| 长期股权投资 | 871,101.96 | 975,216.1 | 1,472,518.11 | 1,592,983.3 |
| 固定资产 | 396,649,423.94 | 409,501,646.72 | 434,849,507.23 | 433,443,511.28 |
| 在建工程 | 2,973,080.49 | 10,940,638.38 | 3,109,600 | 3,928,354.54 |
| 使用权资产 | 10,703,999.86 | 13,598,403.39 | 22,071,625.82 | 24,207,256.3 |
| 无形资产 | 22,565,943.42 | 23,670,029.99 | 21,168,724.88 | 22,257,861.81 |
| 商誉 | 7,664,887.29 | 7,664,887.29 | 7,664,887.29 | 7,664,887.29 |
| 长期待摊费用 | 17,858,096.08 | 12,653,347.55 | 21,169,441.57 | 23,132,609.88 |
| 递延所得税资产 | 55,406,327.01 | 59,662,284.27 | 73,225,865.25 | 73,993,967.52 |
| 其他非流动资产 | 1,724,520 | 1,734,038 | 2,327,188.84 | 8,304,693.88 |
| 非流动资产合计 | 516,417,380.05 | 540,400,491.69 | 587,059,358.99 | 598,526,125.8 |
| 资产总计 | 2,348,400,812.34 | 2,292,212,097.34 | 2,430,758,449.35 | 2,506,127,971.43 |
| 流动负债: | | | | |
| 短期借款 | 25,014,657.53 | 25,014,657.53 | 50,026,383.56 | 60,019,691.77 |
| 应付票据及应付账款 | 447,139,446.7 | 402,619,906.59 | 446,972,029.46 | 450,286,390.27 |
| 其中：应付票据 | - | - | 0 | - |
| 应付账款 | 447,139,446.7 | 402,619,906.59 | 446,972,029.46 | 450,286,390.27 |
| 合同负债 | 8,731,028.54 | 7,243,968.04 | 10,913,616.64 | 11,258,153.62 |
| 应付手续费及佣金 | - | 0 | - | - |
| 应付职工薪酬 | 17,834,106.58 | 32,534,433.74 | 24,044,212.55 | 28,377,920.12 |
| 应交税费 | 10,682,870.26 | 6,769,119.8 | 11,515,903.28 | 10,156,717.7 |
| 其他应付款合计 | 17,210,928.86 | 19,661,531.99 | 26,985,203.77 | 88,981,481.95 |
| 其中:应付利息 | - | 0 | - | - |
| 应付股利 | - | 0 | 13,320,000 | 79,920,000 |
| 应付分保账款 | - | 0 | - | - |
| 一年内到期的非流动负债 | 33,954,764.78 | 37,041,828.66 | 27,207,737.18 | 27,683,584.83 |
| 其他流动负债 | 690,236.03 | 290,082.35 | 1,204,839.82 | 1,368,772.61 |
| 流动负债合计 | 561,258,039.28 | 531,175,528.7 | 598,869,926.26 | 678,132,712.87 |
| 非流动负债: | | | | |
| 长期借款 | 95,500,000 | 104,000,000 | 117,500,000 | 125,700,000 |
| 租赁负债 | 3,629,534.43 | 5,382,513.08 | 10,113,929.84 | 11,037,440.75 |
| 预计负债 | 120,000 | 120,000 | 26,340,249.76 | 25,820,249.76 |
| 递延收益 | 5,824,021.22 | 6,709,127.01 | 7,604,009.04 | 8,531,949.91 |
| 非流动负债合计 | 105,073,555.65 | 116,211,640.09 | 161,558,188.64 | 171,089,640.42 |
| 负债合计 | 666,331,594.93 | 647,387,168.79 | 760,428,114.9 | 849,222,353.29 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 400,517,000 | 400,517,000 | 400,517,000 | 400,517,000 |
| 资本公积 | 555,166,363.79 | 554,758,030.46 | 553,960,780.01 | 553,960,780.01 |
| 减:库存股 | 23,006,777.49 | 23,006,777.49 | 23,006,777.49 | 23,006,777.49 |
| 其他综合收益 | -653,308.3 | -653,308.3 | -653,308.3 | -653,308.3 |
| 盈余公积 | 86,525,659.79 | 86,525,659.79 | 86,525,659.79 | 86,525,659.79 |
| 未分配利润 | 567,247,678.92 | 530,334,434.19 | 560,413,145.97 | 555,297,714.17 |
| 归属于母公司股东权益合计 | 1,585,796,616.71 | 1,548,475,038.65 | 1,577,756,499.98 | 1,572,641,068.18 |
| 少数股东权益 | 96,272,600.7 | 96,349,889.9 | 92,573,834.47 | 84,264,549.96 |
| 股东权益合计 | 1,682,069,217.41 | 1,644,824,928.55 | 1,670,330,334.45 | 1,656,905,618.14 |
| 负债和股东权益合计 | 2,348,400,812.34 | 2,292,212,097.34 | 2,430,758,449.35 | 2,506,127,971.43 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-28 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |